PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHC

Products & Services

Precision Anatomical Pathology for Cancer Cell Growth & Preservation Diagnostic Testing Patient Record & Billing Solutions Diabetes Management Technology Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PHC Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Corporation (Shanghai) Ltd.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PHC Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Corporation (Shanghai) Ltd.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2026 > Announcement of Corporate Officers at PHC Holdings Corporation Effective June 24, 2026

News


2026

NewsMay 27, 2026

Announcement of Corporate Officers at PHC Holdings Corporation Effective June 24, 2026

Please be advised of the Corporate Officers at PHC Holdings Corporation (headquarters: Chiyoda-ku, Tokyo) effective June 24, 2026.

(1) Corporate Officers at PHC Holdings Corporation on June 24, 2026

Position/Title Name Role and Responsibilities
Chief Executive Officer (CEO) Kyoko Deguchi Group Management, Internal Audit
Chief Operating Officer (COO)
Chief Strategy Officer (CSO)
Koichiro Sato Technology, Manufacturing, Procurement,
Business Development, Medical Policy & Public Affairs
Head of Diabetes Management Domain
Head of Healthcare Solutions Domain
Senior Executive Corporate Officer
Chief Financial Officer (CFO)
Kaiju Yamaguchi Corporate Accounting, Corporate Finance, Group Tax
Investor Relations & Corporate Communications
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO)
Ryuichi Hirashima General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation, Information Technology
Executive Corporate Officer Nobuaki Nakamura Head of Diagnostics & Life Sciences Domain
President, Representative Director, PHC Corporation
Corporate Officer Steven Lynum Deputy Head of Diagnostics & Life Sciences Domain
Head of Pathology Business Unit
President, Epredia Holdings Ltd.
Corporate Officer Kenichi Uchino Head of Clinical Testing Business Unit
Representative Director, Member of the Board
President and Chief Executive Officer, LSI Medience Corporation
Corporate Officer Chikara Takauo Head of Life Sciences Business Unit
R&D
Representative Director & Senior Executive Director,
PHC Corporation
Corporate Officer Hideaki Takahashi Head of Healthcare IT Solution Business Unit
President, Representative Director, Wemex Corporation
Corporate Officer Takahide Watanabe Corporate Planning, DX/AI Promotion, Risk Management
Corporate Officer Peter Bodlund Head of Diabetes Management Business Unit
President, Ascensia Diabetes Care Holdings AG

Contact Information:

PHC Holdings Corporation
Investor Relations & Corporate Communications Department
Tel: +81-3-6778-5311
E-mail:phc-pr@gg.phchd.com

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.